Eton Pharmaceuticals (ETON) Gross Profit (QoQ) (2020 - 2025)
Eton Pharmaceuticals (ETON) Gross Profit (QoQ) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Eton Pharmaceuticals | 1.15 Bn | 1.13 Bn | 13.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 66.77% |
| Sep 30, 2025 | -34.12% |
| Jun 30, 2025 | 20.92% |
| Mar 31, 2025 | 52.27% |
| Dec 31, 2024 | 2.76% |
| Sep 30, 2024 | 12.02% |
| Jun 30, 2024 | 12.36% |
| Mar 31, 2024 | 37.93% |
| Dec 31, 2023 | -17.56% |
| Sep 30, 2023 | -54.52% |
| Jun 30, 2023 | 189.36% |
| Mar 31, 2023 | -47.39% |
| Dec 31, 2022 | 215.16% |
| Sep 30, 2022 | -56.25% |
| Jun 30, 2022 | 247.63% |
| Mar 31, 2022 | -76.80% |
| Dec 31, 2021 | 4,628.10% |
| Sep 30, 2021 | -95.82% |
| Jun 30, 2021 | -71.93% |
| Mar 31, 2021 | 4,806.39% |